Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

19,669 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Targeting cancer stem cells with sulforaphane, a dietary component from broccoli and broccoli sprouts.
Li Y, Zhang T. Li Y, et al. Among authors: zhang t. Future Oncol. 2013 Aug;9(8):1097-103. doi: 10.2217/fon.13.108. Future Oncol. 2013. PMID: 23902242
Combination of chemotherapy and cancer stem cell targeting agents: Preclinical and clinical studies.
Li Y, Atkinson K, Zhang T. Li Y, et al. Among authors: zhang t. Cancer Lett. 2017 Jun 28;396:103-109. doi: 10.1016/j.canlet.2017.03.008. Epub 2017 Mar 12. Cancer Lett. 2017. PMID: 28300634 Review.
Kinetics of sulforaphane in mice after consumption of sulforaphane-enriched broccoli sprout preparation.
Li Y, Zhang T, Li X, Zou P, Schwartz SJ, Sun D. Li Y, et al. Among authors: zhang t. Mol Nutr Food Res. 2013 Dec;57(12):2128-36. doi: 10.1002/mnfr.201300210. Epub 2013 Aug 9. Mol Nutr Food Res. 2013. PMID: 23929742 Free PMC article.
Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone function.
Li Y, Zhang T, Schwartz SJ, Sun D. Li Y, et al. Among authors: zhang t. Nutr Cancer. 2011;63(7):1151-9. doi: 10.1080/01635581.2011.596645. Epub 2011 Aug 29. Nutr Cancer. 2011. PMID: 21875325 Free PMC article.
Sulforaphane inhibits pancreatic cancer through disrupting Hsp90-p50(Cdc37) complex and direct interactions with amino acids residues of Hsp90.
Li Y, Karagöz GE, Seo YH, Zhang T, Jiang Y, Yu Y, Duarte AM, Schwartz SJ, Boelens R, Carroll K, Rüdiger SG, Sun D. Li Y, et al. Among authors: zhang t. J Nutr Biochem. 2012 Dec;23(12):1617-26. doi: 10.1016/j.jnutbio.2011.11.004. Epub 2012 Mar 23. J Nutr Biochem. 2012. PMID: 22444872 Free PMC article.
New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential.
Li Y, Zhang T, Schwartz SJ, Sun D. Li Y, et al. Among authors: zhang t. Drug Resist Updat. 2009 Feb-Apr;12(1-2):17-27. doi: 10.1016/j.drup.2008.12.002. Drug Resist Updat. 2009. PMID: 19179103 Free PMC article. Review.
(-)-Epigallocatechin-3-gallate inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cell line Mia Paca-2.
Li Y, Zhang T, Jiang Y, Lee HF, Schwartz SJ, Sun D. Li Y, et al. Among authors: zhang t. Mol Pharm. 2009 Jul-Aug;6(4):1152-9. doi: 10.1021/mp900037p. Mol Pharm. 2009. PMID: 19438225 Free PMC article.
MEK inhibition potentiates the activity of Hsp90 inhibitor 17-AAG against pancreatic cancer cells.
Zhang T, Li Y, Zhu Z, Gu M, Newman B, Sun D. Zhang T, et al. Mol Pharm. 2010 Oct 4;7(5):1576-84. doi: 10.1021/mp900321a. Epub 2010 Jul 29. Mol Pharm. 2010. PMID: 20669973 Free PMC article.
A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells.
Zhang T, Hamza A, Cao X, Wang B, Yu S, Zhan CG, Sun D. Zhang T, et al. Mol Cancer Ther. 2008 Jan;7(1):162-70. doi: 10.1158/1535-7163.MCT-07-0484. Mol Cancer Ther. 2008. PMID: 18202019
Exploiting Ru-induced Lattice Strain in CoRu Nanoalloys for Robust Bifunctional Hydrogen Production.
Li W, Zhao Y, Liu Y, Sun M, Waterhouse GIN, Huang B, Zhang K, Zhang T, Lu S. Li W, et al. Among authors: zhang t. Angew Chem Int Ed Engl. 2020 Oct 26. doi: 10.1002/anie.202013985. Online ahead of print. Angew Chem Int Ed Engl. 2020. PMID: 33105050
19,669 results
Jump to page
Feedback